Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Philippines Pharma Industry Forecasts Slower Growth This Year

This article was originally published in PharmAsia News

Executive Summary

The Philippines' pharmaceutical industry expects the economic situation in the country to lead to slower sales growth this year at a time when the patents of some local companies also expire. The Pharmaceutical and Healthcare Association of the Philippines projects sales growth at no more than 6 percent, down from 10.2 percent last year. The expected 5-6 percent growth rate is expected to be supported in part by increased research and development by the industry. PHAP Executive Director Reiner Gloor said R&D is of greater importance as the local industry meets global competition. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts